Evidence map›Paper›PMID 27770429›Full record

ArticleEJNMMI physics2016

Radiation dosimetry of the α

Mathias Kranz, Bernhard Sattler, Solveig Tiepolt, Stephan Wilke, Winnie Deuther-Conrad, Cornelius K Donat, Steffen Fischer, Marianne Patt, Andreas Schildan, Jörg Patt and 5 more

Open access · goldAbstract read
In one paragraph

Article in EJNMMI physics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. CXCR4-targeted PET imaging of glioblastoma using [EJNMMI radiopharmacy and chemistry · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Dosimetry of a NovelCancers · 2023
    Article
  6. From bench to bedside:EJNMMI research · 2023
    Article
  7. Article
  8. Article
  9. Preclinical Incorporation Dosimetry of [Molecules (Basel, Switzerland) · 2020
    Article
  10. Preclinical Evaluation of Benzazepine-Based PET Radioligands (Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Article
  11. News and views on in-vivo imaging of neurotransmission using PET and MRI.The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... · 2017
    Review
  12. Human biodistribution and dosimetry of [Nuclear medicine and biology · 2017
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Mathias KranzInstitute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318, Leipzig, Germany.
Bernhard SattlerDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Solveig TiepoltDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Stephan WilkeDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Winnie Deuther-ConradInstitute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318, Leipzig, Germany.
Cornelius K DonatInstitute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318, Leipzig, Germany.
Steffen FischerInstitute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318, Leipzig, Germany.
Marianne PattDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Andreas SchildanDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Jörg PattDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
René SmitsABX advanced biochemical compounds Ltd., Radeberg, Germany.
Alexander HoeppingABX advanced biochemical compounds Ltd., Radeberg, Germany.
Jörg SteinbachInstitute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318, Leipzig, Germany.
Osama SabriDepartment of Nuclear Medicine, University Hospital Leipzig, Leipzig, Germany.
Peter BrustInstitute of Radiopharmaceutical Cancer Research, Research Site Leipzig, Helmholtz-Zentrum Dresden-Rossendorf, Permoserstraße 15, 04318, Leipzig, Germany. p.brust@hzdr.de.ORCID http://orcid.org/0000-0001-5555-7058
University Hospital Leipzig · DEHelmholtz-Zentrum Dresden-Rossendorf · DEHammersmith Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBoth enantiomers of [

resultsThe excreting organs (urinary bladder, kidneys, and liver) receive the highest organ doses in all species. Hence, a renal/hepatobiliary excretion pathway can be assumed. In addition, the ED conversion factors of 12.1 μSv/MBq (mice), 14.3 μSv/MBq (piglets), and 23.0 μSv/MBq (humans) were calculated which are well within the order of magnitude as known from other

conclusionsAlthough both enantiomers of [

Indexed as

(+)-[18F]flubatineDosimetryImage-based internal dosimetryNicotinic receptorsOLINDA/EXMPreclinical hybrid PET/MRIRadiation safety

Identifiers

PMID27770429
PMCPMC5074934
OpenAlexW2536357427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.